Total Funding
94
79
Total FundingPost-IPO Equity raised
Growth Score
10 pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21518
Caliway is a biopharmaceutical company that develops drugs for medical aesthetic and anti-aging medicine products.
Ling Yu-Fang: CEO
About the Company
Caliway is a clinical-stage biotech firm that focuses on small-molecule therapeutics for aesthetic medicine and inflammatory diseases. Caliway's leading candidate, CBL-514, is a lipolysis injectable in Phase II targeting localized fat reduction, cellulite, and Dercum’s disease. The company also develops preclinical programs for obesity, skin
aging, and hyperpigmentation.
